CAIRE Eclipse 5 Manuel D'utilisation page 3

Council Directive 2012/19/EU: waste electrical
and electronic equipment (WEEE)
WEEE
IEC 60601-1: Medical electrical equipment Part
1 General requirements for basic safety and
essential performance
Drip Proof Equipment - IP22: The
Eclipse 5 and the AC power supply
provide protection against the harmful
effects of ingress of liquids (IP22 per
IEC 60529)
IEC 60601-1-8
Low Priority Technical Alarm
FCC NOTICE:
This device may contain CYBLE-022001-00,
including the antenna 2450AT18B100 from
Johnson Technology, complies with par 15 of the
FCC rules. The device meets the requirements for
modular transmitter approval as detailed in FCC
public Notice DA00-1407. Transmitter operation
is subject to the following two conditions (1) This
device may not cause harmful interference, and (2)
This device must accept any interference received,
including interference that may cause undesired
operation.
This product may be covered by one or more
patents, US and international. Please visit our
website below for the listing of applicable patents.
Pat.: www.caireinc.com/corporate/patents/.
Aircraft Use:
CAIRE confirms that this machine meets
the Federal Aviation Administration (FAA)
requirements (RTCA/DO-160, section 21, category
M) for all phases of air travel.
Wireless Technology
Technology used
Connection types
Frequency
Max RF power output
Operating range
It is recommended that the machine is at a
minimum distance of 0.43" (1.1 cm) from the body
during operation. Not applicable to masks, air
tubing, or accessories.
Bluetooth
SSP, iAP2, GATT
2402 to 2480 MHz
+4 dBm
10m (Class 2)
What is the Oxygen
Concentrator
The air we breathe contains approximately 21%
oxygen, 78% nitrogen, and 1% other gasses. In
the Eclipse 5, room air is drawn into the machine
through the air intakes. It then passes through an
adsorbent material called molecular sieve. This
material separates the oxygen from the nitrogen and
allows only the oxygen to pass through. The result
is a flow of high-concentration oxygen delivered to
the user.
The Eclipse 5 combines advanced oxygen con-
centrator and oxygen conserving technologies to
create a portable device that allows for maximum
portability and ambulation. The advanced pulse
flow delivery quickly senses when the user breathes
in and delivers a pulse of oxygen at the beginning
of each inhalation. Pulse flow delivery is ideal for
activities and time away from home. It conserves
oxygen and extends battery life as opposed to con-
tinuous flow. The Eclipse 5 is lightweight enough
to be carried via handle or cart. It can be operated
on AC, DC (vehicle) or battery power.
The Essential Performance of the Eclipse 5 is to
provide oxygen concentrations between 82% to
96% at the prescribed flow setting. If Essential
Performance cannot be attained the Eclipse 5 Low
Priority Technical Alert will be activated. If the
Eclipse 5 is exposed to an extreme electromagnetic
disturbance the device may shut down without
activating the alert.
The Eclipse Oxygen System is intended for the
administration of supplemental oxygen to the
patient continuously in the end user's home or for
their portable needs outside the home and can also
be used in institutions such as nursing homes or
sub-acute care facilities. The device is not intended
for life support nor does it provide any patient
monitoring capabilities. The instruction manual
of the device recommends an alternate source of
supplemental oxygen in the event of power outage,
alarm condition or mechanical failure.
The device is used by COPD patients or those
with diminished breathing capacity. The device
is prescribed to the patient. Typically the device
is sold to a provider that is trained to operate and
service the Eclipse 5. The provider trains the user.
Those devices purchased through CAIRE's website
receive setup instructions and the User Manual that
defines setup and usage instructions.
PN 21182453-C4 F | User Manual
Eclipse 5
3 - ENG